CAS 188627-80-7: Eptifibatide

Formel: C₃₅H₄₉N₁₁O₉S₂

InChl: InChI=1/C35H49N11O9S2/c36-31(52)26-17-57-56-12-10-27(47)43-22(7-3-4-11-39-35(37)38)32(53)41-16-28(48)44-25(14-29(49)50)34(55)45-24(13-18-15-40-20-6-2-1-5-19(18)20)30(51)21-8-9-23(42-21)33(54)46-26/h1-2,5-6,15,21-26,40,42H,3-4,7-14,16-17H2,(H2,36,52)(H,41,53)(H,43,47)(H,44,48)(H,45,55)(H,46,54)(H,49,50)(H4,37,38,39)/t21?,22-,23-,24-,25-,26-/m0/s1

Synonyme:

• [3-carbamoyl-11-{4-[(diaminomethylidene)amino]butyl}-20-(1H-indol-3-ylmethyl)-1,9,12,15,18,21-hexaoxodocosahydro-7H-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosin-17-yl]acetic acid
• [(1S,4R,12S,18S,21S)-12-(4-carbamimidamidobutyl)-4-carbamoyl-21-(1H-indol-3-ylmethyl)-2,10,13,16,19,22-hexaoxo-6,7-dithia-3,11,14,17,20,26-hexaazabicyclo[21.2.1]hexacos-18-yl]acetic acid
• Map-Lys-Gly-Asp-Trp-Pro-Cys-Nh2
• Integrelin
• N6-(Aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl-L-lysylglycyl-L-a-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide
• [(3R,11S,17S,20S,25aS)-11-(4-carbamimidamidobutyl)-3-carbamoyl-20-(1H-indol-3-ylmethyl)-1,9,12,15,18,21-hexaoxodocosahydro-7H-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosin-17-yl]acetic acid
• Eptifibatide Acetate

Eptifibatide

CAS: 188627-80-7

Eptifibatide, a RGD mimetic, is a glycoprotein (GP) IIb/IIIa receptor antagonist. Clinically, the peptide is …

• Formel: C₃₅H₄₉N₁₁O₉S₂
• Reinheit: ≥99%
• Farbe und Form: White Lyophilisate
• Molekulargewicht: 831.97

Eptifibatide

CAS: 188627-80-7

Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi

• Formel: C₃₅H₄₉N₁₁O₉S₂
• Farbe und Form: White Powder
• Molekulargewicht: 831.31561

L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1→6)-disulfide

CAS: 188627-80-7

• Formel: C₃₅H₄₉N₁₁O₉S₂
• Reinheit: 98%
• Farbe und Form: Solid
• Molekulargewicht: 831.9619

Eptifibatide

CAS: 188627-80-7

• Formel: C₃₅H₄₉N₁₁O₉S₂
• Molekulargewicht: 831.96

Eptifibatide Acetate

CAS: 188627-80-7

• Formel: C₃₅H₄₉N₁₁O₉S₂
• Reinheit: 95%~99%
• Farbe und Form: White to Off-white Powder
• Molekulargewicht: 831.962

Eptifibatide

CAS: 188627-80-7

• Formel: C₃₅H₄₉N₁₁O₉S₂
• Molekulargewicht: 831.97

Human Eptifibatide

CAS: 188627-80-7

• Farbe und Form: White Lyophilised Powder
• Molekulargewicht: 831.96g/mol

Eptifibatide

CAS: 188627-80-7

Applications An arginine-glycine-aspartate-mimetic, reversibly binds to platelets to reduce the risk of cardiac ischemic events. …

• Formel: C₃₅H₄₉N₁₁O₉S₂
• Farbe und Form: Off White Solid
• Molekulargewicht: 831.96

Eptifibatide acetate

CAS: 188627-80-7

Inhibits platelet glycoprotein IIb/IIIa receptors

• Formel: C₃₅H₄₉N₁₁O₉S₂·xC₂H₄O₂
• Reinheit: Min. 95%
• Farbe und Form: Powder
• Molekulargewicht: 831.96 g/mol

Eptifibatide

CAS: 188627-80-7

Eptifibatide is a drug that is used in the treatment of congestive heart failure, acute …

• Formel: C₃₅H₄₉N₁₁O₉S₂
• Reinheit: Min. 95%
• Molekulargewicht: 831.98 g/mol

Eptifibatide

CAS: 188627-80-7

Eptifibatide is a drug that is used in the treatment of myocardial infarcts. It is …

• Formel: C₃₅H₄₉N₁₁O₉S₂
• Reinheit: Min. 95%
• Molekulargewicht: 831.96 g/mol